FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212769897> ?p ?o ?g. }

• W4212769897 abstract "Shock wave lithotripsy (SWL) is a widely used method to treat renal and ureteral stone. It fragments stones into smaller pieces that are then able to pass spontaneously down the ureter and into the bladder. Alpha-blockers may assist in promoting the passage of stone fragments, but their effectiveness remains uncertain. OBJECTIVES: To assess the effects of alpha-blockers as adjuvant medical expulsive therapy plus usual care compared to placebo and usual care or usual care alone in adults undergoing shock wave lithotripsy for renal or ureteral stones.We performed a comprehensive literature search of the Cochrane Library, the Cochrane Database of Systematic Reviews, MEDLINE, Embase, several clinical trial registries and grey literature for published and unpublished studies irrespective of language. The date of the most recent search was 27 February 2020.We included randomized controlled trials of adults undergoing SWL. Participants in the intervention group had to have received an alpha-blocker as adjuvant medical expulsive therapy plus usual care. For the comparator group, we considered studies in which participants received placebo.Two review authors independently selected studies for inclusion/exclusion, and performed data abstraction and risk of bias assessment. We conducted meta-analysis for the identified dichotomous and continuous outcomes using RevManWeb according to Cochrane methods using a random-effects model. We judged the certainty of evidence on a per outcome basis using GRADE.We included 40 studies with 4793 participants randomized to usual care and an alpha-blocker versus usual care alone. Only four studies were placebo controlled. The mean age of participants was 28.6 to 56.8 years and the mean stone size prior to SWL was 7.1 mm to 13.2 mm. The most widely used alpha-blocker was tamsulosin; others were silodosin, doxazosin, terazosin and alfuzosin. Alpha-blockers may improve clearance of stone fragments after SWL (risk ratio (RR) 1.16, 95% confidence interval (CI) 1.09 to 1.23; I² = 78%; studies = 36; participants = 4084; low certainty evidence). Based on the stone clearance rate of 69.3% observed in the control arm, an alpha-blocker may increase stone clearance to 80.4%. This corresponds to 111 more (62 more to 159 more) participants per 1000 clearing their stone fragments. Alpha-blockers may reduce the need for auxiliary treatments after SWL (RR 0.67, 95% CI 0.45 to 1.00; I² = 16%; studies = 12; participants = 1251; low certainty evidence), but also includes the possibility of no effect. Based on a rate of auxiliary treatments in the usual care arm of 9.7%, alpha-blockers may reduce the rate to 6.5%. This corresponds 32 fewer (53 fewer to 0 fewer) participants per 1000 undergoing auxiliary treatments. Alpha-blockers may reduce major adverse events (RR 0.60, 95% CI 0.46 to 0.80; I² = 0%; studies = 7; participants = 747; low certainty evidence). Major adverse events occurred in 25.8% of participants in the usual care group; alpha-blockers would reduce this to 15.5%. This corresponds to 103 fewer (139 fewer to 52 fewer) major adverse events per 1000 with alpha-blocker treatment. None of the reported major adverse events appeared drug-related; most were emergency room visits or rehospitalizations. Alpha-blockers may reduce stone clearance time in days (mean difference (MD) -3.74, 95% CI -5.25 to -2.23; I² = 86%; studies = 14; participants = 1790; low certainty evidence). We found no evidence for the outcome of quality of life. For those outcomes for which we were able to perform subgroup analyses, we found no evidence of interaction with stone location, stone size or type of alpha-blocker. We were unable to conduct an analysis by lithotripter type. The results were also largely unchanged when the analyses were limited to placebo controlled studies and those in which participants explicitly only received a single SWL session.Based on low certainty evidence, adjuvant alpha-blocker therapy following SWL in addition to usual care may result in improved stone clearance, less need for auxiliary treatments, fewer major adverse events and a reduced stone clearance time compared to usual care alone. We did not find evidence for quality of life. The low certainty of evidence means that our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect." @default.
• W4212769897 created "2022-02-24" @default.
• W4212769897 creator A5001861927 @default.
• W4212769897 creator A5007821932 @default.
• W4212769897 creator A5013238443 @default.
• W4212769897 creator A5015381391 @default.
• W4212769897 creator A5024188537 @default.
• W4212769897 creator A5033402992 @default.
• W4212769897 creator A5070114853 @default.
• W4212769897 creator A5079046602 @default.
• W4212769897 date "2020-11-12" @default.
• W4212769897 modified "2023-10-11" @default.
• W4212769897 title "Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults" @default.
• W4212769897 cites W133597160 @default.
• W4212769897 cites W1510740186 @default.
• W4212769897 cites W1511358911 @default.
• W4212769897 cites W1576470431 @default.
• W4212769897 cites W1583848026 @default.
• W4212769897 cites W1592907179 @default.
• W4212769897 cites W162035010 @default.
• W4212769897 cites W170361755 @default.
• W4212769897 cites W1799472848 @default.
• W4212769897 cites W1838613272 @default.
• W4212769897 cites W1882667856 @default.
• W4212769897 cites W1963602281 @default.
• W4212769897 cites W1965328116 @default.
• W4212769897 cites W1965375861 @default.
• W4212769897 cites W1965414843 @default.
• W4212769897 cites W1974362299 @default.
• W4212769897 cites W1975221378 @default.
• W4212769897 cites W1978751859 @default.
• W4212769897 cites W1980644902 @default.
• W4212769897 cites W1980684392 @default.
• W4212769897 cites W1984004926 @default.
• W4212769897 cites W1984278476 @default.
• W4212769897 cites W1985167153 @default.
• W4212769897 cites W1985954431 @default.
• W4212769897 cites W1989124753 @default.
• W4212769897 cites W1990222007 @default.
• W4212769897 cites W1992583601 @default.
• W4212769897 cites W1994856729 @default.
• W4212769897 cites W1995189923 @default.
• W4212769897 cites W1996199926 @default.
• W4212769897 cites W2000853538 @default.
• W4212769897 cites W2005876754 @default.
• W4212769897 cites W2014667320 @default.
• W4212769897 cites W2022358343 @default.
• W4212769897 cites W2022916835 @default.
• W4212769897 cites W2025729682 @default.
• W4212769897 cites W2037377025 @default.
• W4212769897 cites W2040643763 @default.
• W4212769897 cites W2045993996 @default.
• W4212769897 cites W2046733578 @default.
• W4212769897 cites W2050344517 @default.
• W4212769897 cites W2051721229 @default.
• W4212769897 cites W2053978887 @default.
• W4212769897 cites W2056785271 @default.
• W4212769897 cites W2056899793 @default.
• W4212769897 cites W2057270824 @default.
• W4212769897 cites W2058137481 @default.
• W4212769897 cites W2063521304 @default.
• W4212769897 cites W2064720974 @default.
• W4212769897 cites W2066505346 @default.
• W4212769897 cites W2068385706 @default.
• W4212769897 cites W2073078289 @default.
• W4212769897 cites W2077963107 @default.
• W4212769897 cites W2079081831 @default.
• W4212769897 cites W2079606703 @default.
• W4212769897 cites W2084874130 @default.
• W4212769897 cites W2084886742 @default.
• W4212769897 cites W2089952647 @default.
• W4212769897 cites W2090612179 @default.
• W4212769897 cites W2092463481 @default.
• W4212769897 cites W2093735797 @default.
• W4212769897 cites W2100007591 @default.
• W4212769897 cites W2101778674 @default.
• W4212769897 cites W2104675861 @default.
• W4212769897 cites W2111323078 @default.
• W4212769897 cites W2114427697 @default.
• W4212769897 cites W2117779045 @default.
• W4212769897 cites W2118184961 @default.
• W4212769897 cites W2120799556 @default.
• W4212769897 cites W2125435699 @default.
• W4212769897 cites W2126930838 @default.
• W4212769897 cites W2128778552 @default.
• W4212769897 cites W2130400278 @default.
• W4212769897 cites W2130527709 @default.
• W4212769897 cites W2134236426 @default.
• W4212769897 cites W2142269413 @default.
• W4212769897 cites W2143897535 @default.
• W4212769897 cites W2154316284 @default.
• W4212769897 cites W2157078655 @default.
• W4212769897 cites W2159025450 @default.
• W4212769897 cites W2161206218 @default.
• W4212769897 cites W2162021735 @default.
• W4212769897 cites W2163742315 @default.
• W4212769897 cites W2166959496 @default.
• W4212769897 cites W2168471323 @default.
• W4212769897 cites W2171310196 @default.
• W4212769897 cites W2171942415 @default.

• next